Building Back Better: Opportunities For Advisers

17th March 2022

Andrew Aldridge, Partner & Head of Marketing at Deepbridge, recently spoke with Professional Adviser to discuss the UK Government's current tagline of 'Building Back Better' which is focused on the realisation that we all can live in a smarter way and that the UK has the opportunity to be at the forefront of twenty-first century sustainable innovation.

GenoME Diagnostics Awarded £50K To Aid Early Detection Of Ovarian Cancer

12th March 2022

GenoME Diagnostics, an investee company within Deepbridge's Life Sciences SEIS portfolio has recently won a £50,000 award that is to be given to Shannon Beattie (CEO - GenoME Diagnostics) as part of the celebrations marking International Women’s Day on March 8th 2022, which will be used to aid early detection of ovarian cancer.

Deepbridge Expands Innovation SEIS Fund

17th February 2022

As of 16th February 2022, Deepbridge Capital is opening a new £1 million tranche of the Deepbridge Innovation SEIS fund. 

The Deepbridge Innovation SEIS enables private investors to access a portfolio of early-stage companies within the UK's vibrant technology sector, whilst investors are able to benefit from the generous potential tax reliefs via the Government's Seed Enterprise Investment Scheme. 

Deepbridge Deploys £50M into UK Life Sciences Companies

27th October 2021

Deepbridge Capital has deployed over £50 million of capital into UK life sciences companies.

The Deepbridge Life Sciences EIS was launched in 2017 as our first life sciences focused EIS fund, providing private investors with access to a portfolio of early-stage investee companies across the biopharmaceutical, biotechnology, medical technology and digital healthcare sectors.